Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cryoanesthesia for Intravitreal Injections
NCT02872012Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Mar 2016
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (6 arms), sponsored by University of Michigan. Primary endpoint: Subjective Injection Pain at 0 weeks. Started Mar 2016; status: completed.
Beyond the preview
Go deeper on NCT02872012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872012.